Valeos Pharma A/S: Financial statements 2022
CVR: 39696614
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Valeos Pharma A/S (CVR 39696614) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,489,428 and a net result of DKK -11,425,601 compared with DKK -6,408,155 the year before. Equity in the 2022 report amounted to DKK 5,105,940. The solvency ratio was 8.9%. The company had 10 employees in the financial year.
- Gross Profit
- DKK -6,489,428
- Profit/Loss
- DKK -11,425,601
- Equity
- DKK 5,105,940
- Total Assets
- DKK 57,321,623
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -6.5M | -11.4M | 5.1M | 10 |
| 2021 | - | -3.4M | -6.4M | 16.5M | 7 |
| 2020 | - | -1.3M | -1.7M | -1.4M | 2 |
Official annual report
Keep an eye on Valeos Pharma A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Valeos Pharma A/S has published its annual report for 2021. Gross profit came to DKK -3,379,088, and the net result was DKK -6,408,155.
As of July 4, 2022, Kristian Schrøder Hart-Hansen has joined the board of directors of Valeos Pharma A/S.
As of July 4, 2022, Henrik Kristian Moltke has joined the board of directors of Valeos Pharma A/S.
As of July 4, 2022, Glenn Steven Nielsen has left the board of directors of Valeos Pharma A/S.
On July 4, 2022, the company changed its name from Valeos A/S to Valeos Pharma A/S.
As of July 3, 2022, Kristian Schrøder Hart-Hansen has left the board of directors of Valeos Pharma A/S.
As of March 7, 2022, Farzad Jahanshahi is registered as adm. dir. of Valeos Pharma A/S.
As of March 7, 2022, Peter Frederik Andreasen is registered as adm. dir. of Valeos Pharma A/S.
As of March 7, 2022, Farzad Jahanshahi has stepped down as adm. dir. of Valeos Pharma A/S.
As of March 7, 2022, Birgitte Steen Frydland has stepped down as adm. dir. of Valeos Pharma A/S.
About Valeos Pharma A/S
Valeos Pharma A/S is a Danish company of the type Aktieselskab based in Holeby, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Valeos A/S and Valeos ApS. The management consists of Peter Frederik Andreasen. The board consists of Glenn Steven Nielsen (chair), Kristian Schrøder Hart-Hansen, Michael Halborg-Bendtsen and Peter Frederik Andreasen. The company is owned by A. Rosen Holding ApS, MSG Capital APS and Kleingut ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 975,949 and a net result of DKK -13,487,363 compared with DKK -16,944,710 the year before. Equity in the 2025 report amounted to DKK -6,687,169.